Timothy Scott Ulleseit, PA
Physician Assistant · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 1 carrier
- Offices
- 5
Offices
5 locations · University Healthcare Alliance · 334 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
2 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Timothy Scott Ulleseit’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$10,375
Medicare paid this office $10,375 for 121 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 26 | $1,673 | $60 |
| Short return visit (20+ min) | 19 | $1,473 | $78 |
| Short return visit (20+ min) | 38 | $1,399 | $37 |
| Short return visit | 17 | $292 | $16 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
| Removal of tissue | 1-10 | None |
Who their Medicare patients are
121 Original Medicare patients in 2024. Average age 71 · Women 59% · Also on Medicaid 28% · Health risk score 1.20. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 65% · Depression 27% · Diabetes 26% · Chronic kidney disease 20% · Coronary heart disease 17% · COPD 17% · Heart failure 16% · Atrial fibrillation 15% · Cancer 11%.
The office billed $42,558, Medicare allowed $12,835 and paid $10,375; for 222 services of 24 kinds; $2,885 of it was for drugs given in the office and $7,490 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 121 | 222 | 71 | 1.20 | $42,558 | $10,375 |
| 2023 | 206 | 289 | 69 | 1.30 | $61,501 | $14,083 |
| 2022 | 171 | 240 | 67 | 1.50 | $48,272 | $10,453 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Short return visit (20+ min) | 103 | $4,423 | $39 |
| Return visit (30+ min) | 68 | $4,064 | $50 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 18 | $2,421 | $134 |
| Long return visit (40+ min) | 15 | $1,351 | $90 |
| Short return visit | 35 | $764 | $21 |
2022: 4 services
| Return visit (30+ min) | 58 | $4,009 | $61 |
| Short return visit (20+ min) | 80 | $3,561 | $40 |
| Long return visit (40+ min) | 18 | $1,518 | $76 |
| Short return visit | 36 | $732 | $19 |
Medicaid work
$1,324 in 2024
Medicaid paid $1,324 for 722 billed services this clinician did in 2024, up to 99 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Hospital outpatient clinic visit for assessment and management of a patient | 241 | $1,076 |
| Return visit (30+ min) | 85 | $160 |
| Short return visit (20+ min) | 193 | $64 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 71 | $19 |
| Short return visit | 75 | $6 |
| COMPREHENSIVE METABOLIC PANEL | 24 | $0 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 33 | $0 |
| 2024 | 722 | 7 | 99 | $1,324 |
| 2023 | 2,846 | 9 | 117 | $6,642 |
| 2022 | 2,342 | 10 | 97 | $3,651 |
| 2021 | 26 | 1 | 25 | $0 |
See the largest Medicaid services in earlier years
2023
| Hospital outpatient clinic visit for assessment and management of a patient | 1,153 | $3,218 |
| Return visit (30+ min) | 339 | $1,221 |
| Short return visit (20+ min) | 590 | $1,198 |
| Short return visit | 250 | $344 |
| Infectious disease (viral respiratory tract infection), pathogen-specific RNA, 4 targets (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], influenza A, influenza B, respiratory syncytial virus [RSV]), upper respiratory specimen, each pathogen reported as detected or not detected | 13 | $215 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 95 | $173 |
| COMPREHENSIVE METABOLIC PANEL | 81 | $164 |
| Hemoglobin A1C level | 12 | $73 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 313 | $36 |
2022
| Hospital outpatient clinic visit for assessment and management of a patient | 1,036 | $2,568 |
| Short return visit (20+ min) | 513 | $327 |
| Return visit (30+ min) | 232 | $297 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 13 | $145 |
| Infectious disease (viral respiratory tract infection), pathogen-specific RNA, 4 targets (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], influenza A, influenza B, respiratory syncytial virus [RSV]), upper respiratory specimen, each pathogen reported as detected or not detected | 51 | $120 |
| Short return visit | 212 | $107 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 39 | $58 |
| COMPREHENSIVE METABOLIC PANEL | 37 | $15 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 195 | $13 |
| Infectious agent detection by nucleic acid (DNA or RNA); Streptococcus, group A, amplified probe technique | 14 | $0 |
2021
| Hospital outpatient clinic visit for assessment and management of a patient | 26 | $0 |
Drugs they prescribed that Part D paid
$41,527
Pharmacies billed $41,527 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (16 of 596) in 2024. Above the middle of the specialty; the typical physician assistant clinician is at 1%.
496 generic and 88 brand-name prescriptions · $41,527 in drug cost · 27 antibiotic prescriptions to 22 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 13 | $16,576 | $1,275 |
| Atorvastatin | 60 | $1,512 | $25 |
| Albuterol Sulfate Hfa | 24 | $1,039 | $43 |
| Gabapentin | 16 | $454 | $28 |
| Levothyroxine | 32 | $246 | $8 |
See all 16 drugs
| Ozempic | 13 | $16,576 | $1,275 |
| Atorvastatin | 60 | $1,512 | $25 |
| Albuterol Sulfate Hfa | 24 | $1,039 | $43 |
| Gabapentin | 16 | $454 | $28 |
| Levothyroxine | 32 | $246 | $8 |
| Trazodone | 11 | $199 | $18 |
| Losartan | 16 | $182 | $11 |
| Duloxetine | 22 | $166 | $8 |
| Lisinopril | 17 | $111 | $7 |
| Omeprazole | 12 | $99 | $8 |
| Warfarin | 13 | $98 | $8 |
| Amlodipine Besylate | 22 | $93 | $4 |
| Metformin | 13 | $82 | $6 |
| Citalopram Hbr | 13 | $65 | $5 |
| Potassium Chloride | 11 | $46 | $4 |
| Glipizide | 11 | $26 | $2 |
Year by year
| 2024 | 596 | 179 | 3% (16) | 15% | $41,527 |
| 2023 | 1,060 | 229 | 4% (42) | 17% | $108,293 |
| 2022 | 620 | 171 | 4% (23) | None | $58,442 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 31 drugs
| Ozempic | 13 | $15,900 | $1,223 |
| Advair Diskus | 13 | $5,125 | $394 |
| Basaglar Kwikpen U-100 | 11 | $4,992 | $454 |
| Albuterol Sulfate Hfa | 48 | $2,070 | $43 |
| Efavirenz-Emtric-Tenofov Disop | 12 | $1,662 | $139 |
| Atorvastatin | 63 | $1,063 | $17 |
| Gabapentin | 30 | $783 | $26 |
| Tamsulosin | 26 | $480 | $18 |
| Trazodone | 31 | $394 | $13 |
| Omeprazole | 26 | $382 | $15 |
| Hydrocodone-Acetaminophen | 19 | $367 | $19 |
| Famotidine | 13 | $339 | $26 |
| Lisinopril | 46 | $339 | $7 |
| Amlodipine Besylate | 35 | $299 | $9 |
| Pantoprazole | 13 | $285 | $22 |
| Metformin | 28 | $264 | $9 |
| Levothyroxine | 22 | $259 | $12 |
| Sertraline | 26 | $238 | $9 |
| Losartan | 27 | $186 | $7 |
| Potassium Chloride | 16 | $182 | $11 |
| Duloxetine | 15 | $180 | $12 |
| Spironolactone | 11 | $157 | $14 |
| Fluticasone Propionate | 13 | $154 | $12 |
| Nitrofurantoin Mono-Macro | 11 | $149 | $14 |
| Glipizide | 12 | $96 | $8 |
| Warfarin | 14 | $96 | $7 |
| Metoprolol | 14 | $90 | $6 |
| Cephalexin | 11 | $68 | $6 |
| Simvastatin | 14 | $58 | $4 |
| Furosemide | 13 | $50 | $4 |
| Citalopram Hbr | 11 | $44 | $4 |
2022: 12 drugs
| Gabapentin | 18 | $1,218 | $68 |
| Albuterol Sulfate Hfa | 14 | $964 | $69 |
| Atorvastatin | 35 | $629 | $18 |
| Lisinopril | 41 | $254 | $6 |
| Trazodone | 11 | $230 | $21 |
| Amlodipine Besylate | 13 | $197 | $15 |
| Tamsulosin | 13 | $185 | $14 |
| Metformin | 23 | $183 | $8 |
| Sertraline | 17 | $182 | $11 |
| Amoxicillin-Clavulanate Potass | 11 | $77 | $7 |
| Hydrochlorothiazide | 13 | $72 | $6 |
| Prednisone | 11 | $35 | $3 |
Professional record
- NPI
- 1245851120
- Licence
- OR PA207110
- Trained
- Oregon Health Sciences University School of Medicine, 2021
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X); Student in a training program (390200000X)
- Mailing address
- 15425 Los Gatos Blvd Ste 120, Los Gatos, CA, 95032
- NPI first listed
- 2020-05-01
- NPI last updated
- 2024-11-18
- NPI record certified
- 2024-11-18
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2821 Daggett Ave Ste 100, Klamath Falls, OR, 97601 · 2730 South Moody Ave, Portland, OR, 97201